Analogous studies confirmed Bmi1 expression in CD44-positive head and neck squamous cell carcinoma CSCs [28] and in CD49f Sca-1-double positive prostate CSCs [29]. The gene discussed is CD44; the disease is head and neck squamous cell carcinoma.